Virtus LifeSci Biotech Products ETF Rating → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free BBP Stock Alerts $55.46 -0.19 (-0.34%) (As of 05/7/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy2.73Holdings in BBP have an aggregate rating of Moderate Buy based on 581 analyst ratings issued in the past year covering 50 companies (98.4% of the portfolio).BBP Aggregate Price Target$82.7149.14% UpsideHigh Prediction$124.15Average Prediction$82.71Low Prediction$58.52Holdings in BBP have an aggregate price target of $82.71 and a range of $58.52 to $124.15 covering 50 companies (98.4% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.41%TARSTarsus Pharmaceuticals$37.31-1.9%3 of 5 stars2.88$48.38 29.7%8Upcoming Earnings3.31%ADMAADMA Biologics$6.80-1.6%2 of 5 stars3.25$7.88 15.8%4Upcoming Earnings3.21%DCPHDeciphera Pharmaceuticals$25.383 of 5 stars2.30$24.17 -4.8%10Analyst Revision2.90%AGIOAgios Pharmaceuticals$32.42-1.2%1 of 5 stars2.50$35.00 8.0%4Earnings ReportAnalyst Revision2.78%SRPTSarepta Therapeutics$133.66-1.7%4 of 5 stars2.79$160.60 20.2%14Earnings ReportInsider SellingAnalyst Revision2.71%SWTXSpringWorks Therapeutics$45.37-0.8%1 of 5 stars3.00$68.83 51.7%6Earnings ReportAnalyst Forecast2.60%MRNAModerna$120.51-0.5%4 of 5 stars2.25$126.89 5.3%16Earnings ReportAnalyst ForecastAnalyst Revision2.55%LXRXLexicon Pharmaceuticals$1.78+0.3%2 of 5 stars2.67$5.00 181.7%3Analyst Revision2.48%PTCTPTC Therapeutics$31.26-1.7%2 of 5 stars1.92$33.67 7.7%13Positive News2.36%NBIXNeurocrine Biosciences$141.16-1.4%5 of 5 stars2.74$147.88 4.8%23Analyst Revision2.35%ASNDAscendis Pharma A/S$136.31+0.2%2 of 5 stars2.88$173.88 27.6%82.28%KNSAKiniksa Pharmaceuticals$20.30-0.1%3 of 5 stars3.00$31.00 52.7%42.27%BPMCBlueprint Medicines$107.89-0.6%1 of 5 stars2.50$100.31 -7.0%16Analyst ForecastInsider SellingAnalyst RevisionNews Coverage2.23%ITCIIntra-Cellular Therapies$69.99-1.7%5 of 5 stars2.90$90.17 28.8%10Earnings ReportAnalyst ForecastNews Coverage2.12%LGNDLigand Pharmaceuticals$77.76+6.2%5 of 5 stars3.00$116.33 49.6%3Earnings ReportAnalyst ForecastNews Coverage2.07%REGNRegeneron Pharmaceuticals$967.62-0.2%4 of 5 stars2.70$981.71 1.5%202.05%AXSMAxsome Therapeutics$77.50+0.7%4 of 5 stars2.92$122.17 57.6%13Analyst ForecastAnalyst RevisionNews Coverage2.02%AMGNAmgen$300.280.0%5 of 5 stars2.52$305.05 1.6%21Earnings ReportAnalyst Revision2.02%ROIVRoivant Sciences$11.24-1.2%4 of 5 stars2.90$16.90 50.4%10Positive News2.01%UTHRUnited Therapeutics$266.39+0.1%5 of 5 stars2.90$308.78 15.9%10Earnings ReportInsider Selling2.00%HALOHalozyme Therapeutics$44.70+8.5%5 of 5 stars2.86$53.29 19.2%7Analyst ForecastNews Coverage1.98%VRTXVertex Pharmaceuticals$420.50+2.5%4 of 5 stars2.48$432.18 2.8%25Earnings ReportAnalyst Forecast1.93%RYTMRhythm Pharmaceuticals$37.59-4.5%2 of 5 stars3.00$46.40 23.4%5Earnings ReportAnalyst ForecastNews CoverageGap Down1.89%RAREUltragenyx Pharmaceutical$41.90-0.1%4 of 5 stars2.92$87.85 109.7%12Earnings ReportAnalyst Forecast1.89%EXELExelixis$22.06-0.4%5 of 5 stars2.63$26.33 19.4%16Analyst Revision1.85%IMCRImmunocore$59.80-2.0%3 of 5 stars2.87$80.92 35.3%15Analyst Revision1.80%HRMYHarmony Biosciences$31.22-0.4%4 of 5 stars2.50$40.63 30.1%8Gap Up1.78%INSMInsmed$26.10+0.1%4 of 5 stars3.00$44.92 72.1%12Upcoming EarningsAnalyst DowngradeNews Coverage1.77%APLSApellis Pharmaceuticals$42.26-3.7%5 of 5 stars2.87$77.40 83.2%15News CoverageGap Down1.73%IONSIonis Pharmaceuticals$40.65-0.7%4 of 5 stars2.69$57.67 41.9%13Insider SellingNews CoverageGap Down1.73%BNTXBioNTech$89.73-1.3%3 of 5 stars2.27$118.27 31.8%11Analyst ForecastOptions VolumeNews Coverage1.71%CRSPCRISPR Therapeutics$54.17-2.4%3 of 5 stars2.38$76.29 40.8%16Upcoming Earnings1.71%BMRNBioMarin Pharmaceutical$82.540.0%5 of 5 stars2.63$107.50 30.2%19Insider Selling1.69%BIIBBiogen$218.46-0.2%5 of 5 stars2.65$290.92 33.2%26Positive News1.68%FOLDAmicus Therapeutics$10.30-1.2%4 of 5 stars3.00$20.00 94.2%3Upcoming EarningsNews Coverage1.67%BGNEBeiGene$165.35+3.0%3 of 5 stars2.80$250.13 51.3%10Upcoming Earnings1.66%INCYIncyte$54.12-0.5%5 of 5 stars2.47$74.93 38.5%17Gap Down1.61%TBPHTheravance Biopharma$9.57+0.3%1 of 5 stars3.00$20.50 114.2%2Upcoming Earnings1.61%GILDGilead Sciences$65.22-0.4%5 of 5 stars2.39$83.69 28.3%181.61%ALNYAlnylam Pharmaceuticals$153.79-0.3%5 of 5 stars2.59$216.19 40.6%17Earnings ReportAnalyst Forecast1.51%BBIOBridgeBio Pharma$27.44-1.3%5 of 5 stars2.80$47.82 74.3%101.49%MIRMMirum Pharmaceuticals$25.86-0.2%4 of 5 stars3.11$51.70 99.9%91.44%LEGNLegend Biotech$45.54-1.0%2 of 5 stars2.92$82.64 81.5%12Upcoming Earnings1.44%IRWDIronwood Pharmaceuticals$8.11-0.1%4 of 5 stars3.00$19.80 144.1%5Upcoming Earnings1.43%BCRXBioCryst Pharmaceuticals$5.18-1.5%4 of 5 stars3.00$14.00 170.3%7Earnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap Up1.39%TVTXTravere Therapeutics$6.86+1.6%2 of 5 stars2.64$16.69 143.3%14Earnings ReportAnalyst ForecastNews Coverage1.26%SAGESage Therapeutics$12.81-1.3%4 of 5 stars2.12$37.67 194.0%171.22%ACADACADIA Pharmaceuticals$16.97-1.6%4 of 5 stars2.80$31.75 87.1%15Analyst Forecast1.15%AUPHAurinia Pharmaceuticals$5.09-0.6%1 of 5 stars2.75$10.00 96.5%4Analyst Revision1.06%ZLABZai Lab$16.88+1.2%2 of 5 stars3.00$64.22 280.5%5 This page (NYSEARCA:BBP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
